お知らせ • Apr 14
Lyra Therapeutics, Inc. announced that it has received $100.494971 million in funding from a group of investors
On April 12, 2022, Lyra Therapeutics, Inc. closed the transaction. The transaction included participation from new investors Venrock Healthcare Capital Partners Fund, L.P., Venrock Healthcare Capital Partners III, L.P. for 321,426 shares and $1,356,417.72 and $7,336,841 warrants, Venrock Healthcare Capital Partners EG, L.P. for 361,628 shares and $1,526,070.16 and $8,254,473.50 warrants, VHCP Co-Investment Holdings III, LLC for 32,161 shares and $135,719.42 and $734,106 warrants, Venrock Healthcare Capital Partners II, L.P. for 148,699 shares and $627,509.78 and $3,394,185.50 warrants and VHCP Co-Investment Holdings II, LLC for 60,256 shares and $254,280.32 and $1,375,394 warrants, funds managed by VR Adviser, LLC, Nantahala Capital Management, LLC, Samsara BioCapital LLC for 1,777,251 shares and $7,499,999.22 and returning investors Perceptive Life Sciences Master Fund, Ltd. for 5,924,170 shares and $24,999,997.40, a fund managed by Perceptive Advisors LLC, North Bridge Venture Partners VI, L.P. for 765,010 shares and $3,228,342.20, a fund managed by North Bridge Venture Partners, Pura Vida Master Fund Ltd for 729,621 shares and proceeds of $3,079,000, Pura Vida X Fund LP for 423,327 shares and $1,786,439.94, funds managed by Pura Vida Investments, LLC, Walleye Opportunities Master Fund Ltd for 63,389 shares and $ 267,501.58, a fund managed by Walleye Capital LLC, Walleye Manager Opportunities LLC for 41,943 shares and $176,999.46, Sea Hawk Multi-Strategy Master Fund Ltd for 31,398 shares and $132,499.56, Lockheed Martin Corporation Master Retirement Trust for 761,507 shares and $3,213,559.54, Rosalind Master Fund L.P. for 1,184,834 shares and $4,999,999.48, a fund managed by Rosalind Advisors, Inc., CVI Investments, Inc. for 236,966 shares and $999,996.52, Soleus Capital Master Fund, L.P. for 592,417 shares and $2,499,999.74, a fund managed by Soleus Capital Management, L.P., Nantahala Capital Partners Limited Partnership for 116,430 shares and $491,334.60, Nantahala Capital Partners II Limited Partnership for 165,008 shares and $696,333.76, Armistice Capital Master Fund Ltd. for 355,450 shares and $1,499,999, a fund managed by Armistice Capital LLC, Nantahala Capital Partners SI, Lp for 1,186,041 shares and $5,005,093, Pinehurst Partners, L.P. for 66,464 shares and $280,478.08, Corbin Capital Partners, L.P., Corbin Hedged Equity Fund, L.P. for 23,231 shares and $98,034.82, Samsara Biocapital, L.P. and Altium Growth Fund, LP for 118,483 shares and $499,998.26, a fund managed by Altium Capital Management LP., NCP RFM LP for 129,108 shares and $544,835.76, NCP CB LP for 350,558 shares and $1,479,354.76, BLACKWELL PARTNERS LLC - SERIES A for 332,828 shares and $1,404,534.16, MLPF&S Custodian FPO Tim Foster IRRA FBO Tim Foster for 118,483 shares and $499,998.26, individual investors Harlan Waksal for 761,507 shares and$3,213,559.54, North Bridge Venture Partners V-A, L.P. for 1,076,851 shares and $4,544,315.44, North Bridge Venture Partners V-B, L.P. for 527,806 shares and $2,227,341.32, Edward T. Anderson for 118,483 shares and$499,998.26, Craig A. Wheeler for 118,483 shares and $499,998.26 and Highmark Limited for 318,483 shares and $1,343,998.